Association between Single Nucleotide Polymorphisms and Glioma Risk: A Systematic Literature Review

Cancer Invest. 2020 Mar;38(3):169-183. doi: 10.1080/07357907.2020.1719502. Epub 2020 Mar 2.

Abstract

This study aimed to determine the main single nucleotide polymorphisms (SNPs) that are associated with an increased or decreased risk of glioma development in healthy individuals. We conducted a systematic review of the articles published in English on the PUBMED database between January 2008 and December 2017. Our search resulted in a total of 743 articles; however, only 56 were included in this review. A total of 148 polymorphisms were found, which involved 64 different genes. The polymorphisms that were most associated with an increased risk of glioma development were polymorphic variants rs179782, rs13181, and rs3791679 of the genes XRCC1, ERCC2, and EFEMP1, respectively.

Keywords: astrocytoma; glioma; single nucleotide polymorphism (SNP); variant.

Publication types

  • Systematic Review

MeSH terms

  • Brain Neoplasms / genetics*
  • Extracellular Matrix Proteins / genetics
  • Genetic Association Studies / methods*
  • Genetic Predisposition to Disease
  • Glioma / genetics*
  • Humans
  • Polymorphism, Single Nucleotide*
  • X-ray Repair Cross Complementing Protein 1 / genetics
  • Xeroderma Pigmentosum Group D Protein / genetics

Substances

  • EFEMP2 protein, human
  • Extracellular Matrix Proteins
  • X-ray Repair Cross Complementing Protein 1
  • XRCC1 protein, human
  • Xeroderma Pigmentosum Group D Protein
  • ERCC2 protein, human